Warfarin glycosylation invokes a switch from anticoagulant to anticancer activity.

ABSTRACT:

SUBMITTER: Peltier-Pain P 

PROVIDER: S-EPMC3217245 | biostudies-literature | 2011 Aug

REPOSITORIES: biostudies-literature